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Introduction: The association between biomarkers of oxidative stress and the prognosis of patients with
traumatic brain injury (TBI) remains inconclusive.
Objective: The objective was to investigate the association between plasma levels of lipid peroxidation
(thiobarbituric acid reactive species [TBARS]) and protein oxidation (carbonyl) biomarkers and the
hospital mortality of patients with severe TBI.
Methods: Plasma levels of TBARS and carbonyl were determined in 79 consecutive patients with
severe TBI (Glasgow Coma Scale [GCS] ≤8) at a median of 12 hours (interquartile range [IQ] 25-75,
6.5-19.0), 30 hours (IQ 25-75, 24.7-37.0), and 70 (IQ 25-75, 55.0-78.5) hours after TBI and were
compared with age- and sex-matched controls. The association between the TBARS and carbonyl levels
and the hospital mortality was analyzed by multiple logistic regression analysis.
Results: The mean age of patients was 34.8 years. Eighty-six percent were male. The TBARS and
carbonyl levels were significantly higher in patients than in controls. There was a trend (P = .09) for
higher plasma levels of TBARS and carbonyl proteins at 12 hours, but not at 30 or 70 hours, after☆ Conflict of interest: The authors declare that they have no conflicts of interest in the authorship or publication of this contribution.
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523.e12 A. Hohl et al.trauma in nonsurvivors than in survivors. These findings were not confirmed after the adjustments by
multiple logistic regression analysis. The final model showed a higher adjusted odds ratio for death for
patients with admission GCS lower than 5 (odds ratio [OR] = 4.04; 95% confidence interval [CI],
1.33-12.13; P = .01) than those with higher GCS scores. Abnormal pupils were also associated with
higher mortality (OR = 3.97; 95% CI, 1.22-12.13; P = .02). There was a nonsignificant trend for
association between glucose greater than or equal to 150 mm/dL in the first 12 hours and death than
levels between 70 and 149 mg/dL (OR = 2.92; 95% CI, 0.96-9.02; P = .06).
Conclusions: Plasma levels of TBARS and carbonyl increase significantly in the first 70 hours after
severe TBI but are not independently associated with the hospital mortality.
© 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Traumatic brain injury (TBI) is the leading cause of
morbidity and mortality of young people worldwide [1-4].
Traumatic brain injury is more frequent among people living
in low- and middle-income countries, including Brazil
[3,5,6]. After the primary injury related to the trauma itself
(contusions, lacerations, hemorrhage), lesions may be
aggravated at prehospital level or after hospital admission
because of hemodynamic imbalance, intracranial hyperten-
sion, anemia, infections, fever, hypoxia, seizures, and
metabolic and electrolytic imbalance.
The primary damage and its subsequent imbalance may
activate both secondary injury and neuroprotective cascades,
which will interact with a complex biochemical network
leading to neuronal and glial survival or death due to necrosis
and apoptosis [7-10].
An excessive amount of reactive oxygen species (ROS)
generated by several combined mechanisms, including
neutrophils activation, endothelial cells, nerve and glial
cells, iron ions (from hemoglobin degradation in the
hemorrhagic areas), and brain reperfusion [7,8,10,11], has
been implicated in brain lesion in TBI.
The ROS reaction with proteins, deoxyribonucleic acids
(DNA), and lipids, leading to the oxidative damage of cells
and tissues in TBI, has been discussed for more than 20 years
[7,12,13]. Experimental models of TBI in rodents demon-
strated that the damage caused by the oxidative stress might
vary according to the brain structures, trauma intensity, and
time after injury [14]. The role of ROS brain damage in
human TBI has been studied; however, the association
between its plasma markers and the prognosis in humans
remains controversial [15-18].
Statistical models, which combine 2 or more variables of
patient's data to predict clinical outcome, also called prog-
nostic models, have been applied in TBI research [3,6]. The
investigation of variables associated with prognosis may
help in medical decisions as well as in identifying possible
therapeutic targets for the patients. The association between
oxidative stress markers and the prognosis of human TBI
may be affected by several confounding biases in the context
of critically ill patients with TBI. The multiple logistic
regression analysis is useful to reduce the possibility ofconfounding bias leading to spurious associations between
the studied variables and prognosis. Here we investigate the
association between death and oxidative stress estimated by
plasma levels of lipids and proteins peroxidation markers
measured in humans at different times after severe TBI using
a multiple logistic regression analysis.2. Subjects and methods
We included prospectively 79 consecutive adult patients (age
18-80 years) with severe TBI admitted to the intensive care unit
of the Hospital Governador Celso Ramos between April 2006
and April 2008 and who met the inclusion criteria. This is a
public reference hospital for TBI covering the metropolitan area
of Florianopolis city with a population of approximately 1
million people. The neurosurgical team, the intensive care unit
staff, and the research teamwere the same during this study. The
inclusion criteriawereGlasgowComaScale (GCS) score of 8 or
lower after the intensive care admission. Victims of gunshot
injury and patients who evolved to brain death before 24 hours
of admission were excluded. Informed consent was obtained
from families, and patients whose families withdrew consent
were not included in the study. The control group (n = 10)
included healthy voluntary people from the hospital and
laboratory staff of the same age and sex.
Hospital mortality was the dependent variable. The
clinical, demographic, radiological, and neurosurgical inde-
pendent variables analyzed were age, sex, presence of renal
failure (underwent peritoneal dialysis or hemodialysis)
during patient care, computed tomography (CT) findings
(Marshal CT classification and presence of subarachnoid
hemorrhage [SAH]), presence of associated trauma (face,
spinal, thorax, abdomen, or limbs), admission GCS, and
pupil examination at admission.
The CT findings were classified into the 6 categories
according to Marshall et al [19]. Blind CT analysis was done
before the patient's discharge by one of the researchers (EMT)
and confirmed by another, when necessary. Most of these
isolated or combined variables were proven to be associated
with TBI outcome in our and other populations [1,2,3,6,19,20].
Oxidative stress parameters were determined in blood
plasma on the first, second, and third day after TBI. The blood
523.e13Biomarkers and hospital mortality in severe head injurysample was collected as soon as possible on the first day and,
according to the research team schedule possibilities, on the
second and third days. The time for blood sampling was
calculated from the time of injury onward. The time span
between TBI and blood sampling was determined by one of
our researchers (JSG, MMB, or CCP). Five milliliters of
peripheral venous blood was collected and centrifuged. The
plasma was stored for 24 hours at −20°C and then at −70°C
until biochemical analysis. As an index of lipid peroxidation,
the development of thiobarbituric acid reactive species
(TBARS) was measured as previously described [14,21-23].
Briefly, the samples were analyzed by absorbance at 535 nm;
and results were expressed as malondialdehyde (MDA)
equivalents (nanomoles per milligram protein). The TBARS
plasma levels were expressed in nanomoles per milligram
protein × 10−5. The oxidative damage to proteins was assessed
by determining carbonyl groups based on the reaction with
dinitrophenylhydrazine as previously described [14,21-23].
Briefly, proteins were precipitated and dissolved in dinitro-
phenylhydrazine; and absorbance was read at 370 nm. Plasma
levels of carbonyl groups were expressed in nanomoles per
milligram protein × 10−14. Because TBARS and carbonyl
levels show a wide range, their results were expressed asTable 1 Clinical, demographic, radiological, and neurosurgical varia
Variable All patients
n = 79 (%)
Outcome
Survivors
n = 51 (%)
Age
Mean ± SD 34.8 (15.6) 33.5 (14.2)
Sex
Male 68 (86.1) 45 (88.2)
Female 11 (13.9) 6 (11.8)
Renal failure
Yes 9 (11.4) 6 (11.8)
No 70 (88.6) 45 (88.2)
Marshall CT classification
Type I injury 4 (5.1) 3 (5.9)
Type II injury 21 (26.6) 17 (33.3)
Type III injury 9 (11.4) 5 (9.8)
Type IV injury 8 (10.1) 6 (11.8)
Evacuated mass lesion 15 (19) 10 (19.6)
Nonevacuated lesion 22 (27.8) 10 (19.6)
SAH
No 35 (44.3) 24 (47.1)
Yes 44 (55.7) 27 (52.9)
Associated trauma
Yes 47 (59.5) 33 (64.7)
No 32 (40.5) 18 (35.3)
Admission GCS
7 or 8 30 (38.0) 24 (47.1)
5 or 6 16 (20.3) 12 (23.5)
3 or 4 33 (41.8) 15 (29.4)
Admission pupils
Normal 38 (48.1) 31 (60.8)
Abnormal 41 (51.9) 20 (39.2)median and interquartile range (IQ 25-75). The analysis of
oxidative stress parameters was carried out by researchers
blinded for all the clinical, demographic, neurosurgical,
neuroradiological, and hemodynamic variables of patients.
The clinical and hemodynamic parameters, evaluated at
the time of the blood sampling, were blood pressure, heart
rate, respiratory rate, and positive end-expiratory pressure.
The laboratory variables, analyzed on the same sample as for
TBARS and carbonyl measurements, were arterial blood gas,
sodium, potassium, urea, creatinine, hematocrit, hemoglo-
bin, leukocytes, and platelets and were expressed in mean
and standard deviation (SD).
The variables were measured by 3 researchers (JAG, AH,
CCP) using the same standardized protocol previously
approved by the Human Research Ethics Committee of the
Universidade Federal de Santa Catarina.
2.1. Statistical analysis
The univariate analysis was used to determine the
association among the clinical, demographic, radiological,
and neurosurgical variables; TBARS and carbonyl groups
levels; and the hospital mortality. Continuous variablesbles and hospital mortality of patients with severe head injury
Crude OR for
death (95 CI)
P value
Nonsurvivors
n = 28 (%)
37.3 (17.9) NA .43
23 (88.1) 1.0
5 (17.9) 1.63 (0.45-5.92) .46
3 (10.7) 1.0
25 (89.3) 1.11 (0.26-4.83) .89
1 (3.6) 1.0
4 (14.3) 0.71 (0.60-8.70) .79
4 (14.3) 2.40 (0.17-32.90) .51
2 (7.1) 1.0 (0.06-16.0) 1.0
5 (17.9) 1.5 (0.12-18.4) .75
12 (42.9) 3.6 (0.32-40.20) .30
17 (60.7) 1.0
11 (39.3) 1.37 (0.54-3.50) .51
14 (50.0) 1.0
14 (50) 1.83 (0.72-4.70) .23
6 (21.4) 1.0
4 (14.3) 1.33 (0.32-5.64) .69
18 (64.3) 4.8 (1.55-14.81) .006
07 (25.0) 1.0
21 (75.0) 4.65 (1.67-12.94) .003
523.e14 A. Hohl et al.were analyzed by the nonparametric test (Mann-Whitney
test) because of the relative asymmetry in the number of
survivors and nonsurvivors. Differences in plasma levels of
TBARS and carbonyl groups among the 3 blood samples
collected from the patients after the TBI were analyzed by
Wilcoxon signed rank test. Categorical variables were
analyzed by binary logistic regression. The magnitude of
the association between death and the independent
categorical variables was measured by the odds ratio
(OR) and respective 95% confidence interval (CI) estimated
by unconditional logistic regression.
To identify variables that were independently associated
with death, a multiple logistic regression was performed
using the following conditional method. For this analysis,
continuous variables including the biochemical markers of
oxidative stress were categorized. Variables showing an
association with death through the univariate analysis with a
P level of significance lower than .20 were included in the
analysis. The variable “associated trauma” was also included
in the multivariate analysis. The probability of stepwise entry
was .05, and that of removal was .10. The classification
cutoff was .5 with maximum interactions of 20. P levels
lower than .05 were considered significant. To avoid type II
error, we did not adjust for multiple tests using a more
stringent criterion for the P level [24]. Missing cases were
clearly described in the results and tables. Statistical analysis
was done using the SPSS program 10.0 (Chicago, IL).ig. 1 A, Plasma levels of TBARS (expressed as median and
terquartile range) measured in controls (n = 10) and in patients at a
edian of 12 hours (n = 79), 30 hours (n = 69), and 70 hours (n =
8) after the severe TBI. aSignificant difference from the control
roup (P≤ .003). bSignificant difference from 12 and 30 hours (P b
01). B, Plasma levels of carbonyl measured in controls and in
atients after the severe TBI. aSignificant difference from the
ontrol group (P b .001). There was a trend for higher levels of
arbonyl 12 hours (P = .12) and 30 hours (P = .08) after TBI than
ontrols. bSignificant difference from 30 hours (P = .02)
nd csignificant difference from 12 hours (P b .001) after TBI.3. Results
The clinical, demographic, radiological, and neurosurgical
variables and the hospital mortality of patients are shown in
Table 1. The mean age was 34.8 years for patients and 29.6
for controls (P = .30). Eighty-six percent of patients and 80%
of controls were male (P = .45). Twenty-eight patients died
(35.4%). The mean hospitalization time was 20 (±18) days,
29 (±21) days for survivors and 6 (±5) days for nonsurvivors.
The causes of death were TBI itself for 25 patients (89.3%).
One patient died because of heart infarction (3.6%); one because
of pneumonia, pleural effusion, and cardiac arrest (3.6%); and
one because of pneumonia evolving to sepsis, renal failure, and
cardiac arrest (3.6%). These 3 patients died after the third blood
sample collection. There was no association between death and
age, sex, presence of renal failure, admission, tomographic
findings according to Marshal classification and SAH, and
associated trauma (P N .23). There was a significant association
between death and lower scores in the GCS (P = .006) and
anisocoric (P = .04) and mydriatic pupils (P = .001) at
admission. These analyses remain unaltered when excluding
deaths not attributed to TBI (data not shown).
The comparison between the levels of TBARS and
carbonyl at the different times after the severe TBI is shown
in Fig. 1. In comparison to those of non-TBI controls, the
plasma TBARS were significantly increased at 12, 30, andF
in
m
5
g
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p
c
c
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a70 hours after the severe TBI (P b .003). The carbonyl levels
measured 70 hours after the severe TBI were also
significantly higher than those of controls. There was a
trend for higher levels of carbonyl 12 hours (P = .12) and
30 hours (P = .08) after TBI compared with the controls.
The plasma levels of TBARS or carbonyl groups of the
TBI patients and control group, according to the prognosis
(hospital mortality), are shown in Table 2. The TBARS levels
measured 12, 30, and 70 hours after TBI were significantly
higher than those in the controls (P b .01). Carbonyl levels
measured 12 hours after TBI did not rise significantly in
Table 2 Plasma levels of TBARS (nanomoles per milligram protein × 10−5) and protein carbonyl (nanomoles per milligram
protein × 10−14) of controls and survivor and nonsurvivor patients
Biochemical
variables
Control group All patients Outcome P level c
Survivors Nonsurvivors
Plasma sample 1 n = 10 n = 79 n = 51 n = 28
Hours after trauma
(median, IQ 25-75)
NA 12.08 (6.5-19.00) 11.0 (6.5-19) 13.67 (6.25-17.4) .69
TBARS level
(median, IQ 25-75)
14.0 (7.5-18.0) 45.86 (14.66-237.43) 41.64 (10.19-197.10) 57.75 (25.0-389.54) .09
Carbonyl level
(median, IQ 25-75)
20.0 (15.75-24.25) 27.53 (10.56-161.89) 25.31 (9.26-93.04) 54.54 (17.68-211.65) .09
Plasma sample 2 n = 69 b n = 42 n = 27
Hours after trauma
(median, IQ 25-75)
NA 30.58 (24.75-37.0) 30.7 (24.0-37.0) 29.25 (25.25-36.6) .71
TBARS level
(median, IQ 25-75)
14.0 (7.5-18.0) 38.70 (18.8-226.47) 35.2 (16.6-235.62) 42.4 (20.5-223.3) .36
Carbonyl level
(median, IQ 25-75)
20.0 (15.75-24.25) 44.97 (12.37-133.59) 40.05 (12.60-108.49) 67.45 (11.22-149.89) .77
Plasma sample 3 n = 58 a n = 40 n = 18
Hours after trauma
(median, IQ 25-75)
NA 70.0 (55.0-78.5) 71.5 (59.4-80.0) 62.5 (51.1-71.3) .06
TBARS level
(median, IQ 25-75)
14.0 (7.50-18.0) 80.49 (58.55-382.59) 73.70 (56.2-359.6) 92.12 (68.68-491.44) .37
Carbonyl level
(median, IQ 25-75)
20.0 (15.75-24.25) 38.27 (15.93-197.17) 38.20 (15.83-140.52) 52.77 (26.12-295.50) .26
The comparisons among the serum levels of the analyzed biomarkers measured in patients at different times after TBI and controls are shown in Fig. 1.
a Comparisons between plasma levels of TBARS and carbonyl of survivors and nonsurvivors analyzed 12, 30, and 70 hours after severe TBI.
b The third blood sample was not examined in 21 patients. Nine patients died before the collection time, and 12 had no third sample collected.
c The second blood sample was not examined in 10 patients. One patient died before sampling time, and 9 had no second sample collected.
523.e15Biomarkers and hospital mortality in severe head injurycomparison to the controls (P = .29). However, there was a
trend for higher levels of carbonyl groups measured 30 hours
after TBI in comparison to the control group (P = .12).
Carbonyl levels of patients at 70 hours after TBI were
significantly higher than those of controls (P = .03). There
was a trend (P = .09) for higher plasma levels for both
TBARS and carbonyl proteins at 12 hours, but not at 30 or 70
hours (P N .25), after trauma in survivors when compared
with nonsurvivors. A subset analysis of patients with isolated
TBI showed no significant association between the studied
biomarkers and death (P N .20).
In patients, TBARS plasma levels did not change
significantly (P = .23) between the first and the second
blood sampling. However, TBARS plasma levels increased
significantly 70 hours after TBI (P b .001) in comparison to
12 and 30 hours after severe TBI. There was a trend (P = .08)
for higher plasma levels of carbonyl groups measured at 30
hours when compared with levels at 12 hours after severe
TBI. At 70 hours after TBI, plasma levels of carbonyl groups
rose significantly in comparison to those at 30 (P = .02) and
12 (P b .0001) hours after the severe TBI. There were no
statistical differences between the time of the first (P N .69)
and second (P = .71) blood sampling after TBI in survivors
and nonsurvivors. In comparison to survivors, there was a
trend for shorter time between TBI and the third blood
sampling in nonsurvivors (P = .06).One patient died before the second and 9 patients died
before the third sampling. Because of some difficulties in the
schedule of the researchers' team, the second blood sample
was not collected in 9 patients and the third blood sample was
not collected in 12 patients. These blood-sampling failures
occurred by chance and were not related to any clinical or
laboratory criteria that could affect the patient's prognosis.
There were no statistical differences in plasma levels of
TBARS and protein carbonyl groups at the second and third
sampling between survivors and nonsurvivors. The associ-
ation between prognosis and plasma markers of oxidative
stress damage, measured on the third sample collected,
remained nonsignificant after correcting the imbalance in
blood sampling time after TBI (P = .63, data not shown).
Because blood-brain barrier disruption would allow brain-
derived lipid and protein oxidation products to exit into the
plasma, we also investigated the association between lipid
and protein oxidation levels as a function of the different
Marshall CT classifications and presence of SAH. There was
no association between Marshall CT classification and either
TBARS or carbonyl levels among the different Marshall CT
groups (P ≥ .20). Presence of SAH on admission CT was
also not associated with the TBARS and carbonyl levels
measured at the 3 times after TBI (P ≥ .28).
Table 3 shows the association between death and the
clinical and laboratory parameters at the time of the first
Table 3 Clinical and laboratory parameters at the time of the first blood sampling
Variable a All patients
n = 79
Outcome P level b
Survivors n = 51 Nonsurvivors n = 28
Blood pressure
Systolic 126.2 (30.4) 128.5 (30.6) 121.9 (30.1) .37
Diastolic 73.5 (19.6) 75.8 (19.4) 69.5 (19.7) .17
Heart rate 89.6 (22.1) 89.6 (20) 89.5 (26.0) 1.0
Respiratory rate 20.1 (11.0) 20.7 (13.3) 19.0 (4.0) .55
PEEP 5.8 (4.4) 6 (5.2) 5.6 (2.4) .69
Blood gases c
pH 7.37 (0.08) 7.39 (0.07) 7.33 (0.10) .003
pCO2 32.7 (10.5) 31.5 (6.7) 34.9 (15.1) .19
pO2 260.6 (254.0) 246.1 (121.3) 286.9 (397.3) .51
HCO3
− 18.8 (3.5) 19.2 (3.0) 18.3 (4.2) .28
O2 sat 97.0 (12.0) 98.2 (4.9) 94.9 (19.1) .26
pH b7.35 25 (31.3%) 11 (22.4) 14 (51.9)
pH ≥7.35 51 (63.8%) 38 (77.6) 13 (48.1) .01 d
Serum glucose e 167.2 (74.3) 153.8 (60.7) 191.8 (90.7) .04
Between 70 and 149 mg/dL 38 (48.1%) 30 (62.5%) 8 (30.8%)
≥150 mg/dL 36 (45.6%) 18 (37.5%) 18 (69.2%) .01 d
Sodium f 141.1 (7.1) 139.9 (5.6) 143.4 (9.1)
b143 64 (80.0%) 45 (90.0%) 19 (70.4%)
≥144 13 (16.3%) 5 (10.0%) 8 (29.6%) .04 d
Potassium 4.4 (4.1) 4.7 (5.1) 3.9 (0.7) .48
Urea 29.9 (11.4) 29.6 (10.9) 30.5 (12.8) .78
Creatinine 0.93 (0.27) 0.93 (0.25) 0.92 (0.30) .74
Hematocrit 32.82 (6.4) 33.75 (6.5) 31.13 (5.88) .03
b31 28 (35.4%) 13 (25.5%) 15 (53.6%)
≥31 51 (64.6%) 38 (74.5%) 13 (46.4%) .02 d
Hemoglobin g 11.74 (4.18) 12.37 (4.86) 10.55 (2.10) .01
b11 32 (40%) 16 (32.0%) 16 (59.3%)
≥11 45 (56.3%) 34 (68.0%) 11 (40.7%) .03 d
Total leukocytes 15846 (6.990) 15475 (7.374) 16490 (6359) .56
Platelets 189151 (6.0617) 192370 (5.4513) 183667 (7587) .57
PEEP indicates positive end-expiratory pressure.
a All variables are expressed as mean (SD), and some of them are also categorized.
b Statistical analysis by Student t test.
c Gasometric parameters from 3 patients were not determined.
d Statistical analysis by Fisher exact test.
e Serum glucose level from 5 patients was not determined.
f Sodium level from 3 patients was not determined.
g Hemoglobin level from 2 patients was not determined.
523.e16 A. Hohl et al.blood sampling. This analysis was carried out to identify
imbalances between survivors and nonsurvivors of variables
that could affect plasma levels of the oxidative stress markers
leading to a spurious association between oxidative stress
and prognosis.
The laboratory variables were measured on the same
blood sample used to determine plasma TBARS and
carbonyl levels 12 hours after TBI. Patients who died had
significantly higher levels of pH (P = .01), glucose (P = .04),
and sodium than survivors. Nonsurvivors had significantly
lower levels of hematocrit and hemoglobin than those
who survived.
Table 4 shows the final model of multiple logistic
regression analysis that better explains the independent
association among each categorical variable and hospitalmortality. This analysis showed that plasma levels of TBARS
and carbonyl groups were not independently associated with
death (they were not included in the final model). Higher
levels of serum glucose 12 hours after TBI (P =.04), lower
GCS (P = .04), and abnormal pupils (P = .006) at admission
were independently associated with death.4. Discussion
Our results demonstrated that plasma levels of TBARS
and carbonyl groups are significantly higher in the TBI group
than in the healthy controls group, suggesting an association
between oxidative stress damage of lipids and proteins and
Table 4 Multiple logistic regression model that better explains the association between each categorical variable and hospital mortality
Variable All patients
n = 79 (%)
Outcome Crude OR level P level Adjusted
OR a for death
(95% CI)
P level
Survivors
n = 51 (%)
Nonsurvivors
n = 28 (%)
Serum glucose in the first sample
70-149 mg/dL 38 (48.1) 30 (62.5) 8 (30.8) 1.0 1.0
≥150 mg/dL 36 (45.6) 18 (37.5) 18 (69.2) 3.75 (1.36-10.37) .01 2.92 (0.96-9.02) .06
Admission neurological parameters:
GCS ≥5 46 (48.2) 36 (78.3) 15 (45.5) 1.0 1.0
GCS b5 33 (41.8) 10 (21.7) 18 (54.5) 4.32 (1.62-11.51) .003 4.03 (1.33-12.13) .01
Admission pupils
Normal 38 (48.1) 31 (60.8) 07 (25.0) 1.0 1.0
Abnormal 41 (51.9) 20 (39.2) 21 (75.0) 4.65 (1.67-12.94) .003 3.97 (1.22-12.13) .02
a Adjusted OR indicates the magnitude of association between each categorical variable and death, independent of imbalances in the distribution of all
other clinical, demographic, radiological, and neurosurgical variables studied.
523.e17Biomarkers and hospital mortality in severe head injurysevere TBI in humans. Rise in TBARS levels occurred
earlier (during the first 12 hours) than that in carbonyl levels
(second and third day after severe TBI). In an experimental
model, we demonstrated that both TBARS and carbonyl
levels increased in a time-dependent manner in different
brain regions of rodents submitted to experimental TBI [14].
Our findings are in agreement with previous studies
showing an enhancement of oxidative stress damage in
patients with severe TBI [15]. In fact, the brain is particularly
vulnerable to oxidative stress because of its higher rate of
oxygen consumption, higher level of transition metals, and
polyunsaturated fatty acids. The oxidative stress pathways
may be activated by excitatory mechanisms as well as several
secondary mechanisms including reperfusion and iron in its
reduced state resulting from hemoglobin degradation
(Fenton reaction) [14]. The oxidative damage contributes
to mitochondrial dysfunction leading to energy failure. This
could trigger a complex cascade of cellular events, such as
cellular depolarization and Ca+2 influx leading to excitotoxic
and apoptotic neuronal death [14,25].
Using the same biochemical technique as for plasma
TBARS determination, Scholpp et al [18] demonstrated that
there was no difference in the levels of this plasma marker for
lipid peroxidation between patients with TBI 12 to 24 hours
after admission and healthy controls, thus suggesting that it is
not a useful biomarker for oxidative stress damage in TBI.
However, in this study, the patient sample was relatively
small (n = 18), showing a variable degree in TBI severity
(GCS between 3 and 13).
The trend shown by our data for association between
plasma levels of TBARS and carbonyl groups at 12 hours
and mortality in severe TBI did not become significant after
the multiple logistic regression analysis. This is in
contradiction to the previous findings of Nayak et al
[15,16], which demonstrated an association between
mortality and higher levels of TBARS from the erythro-
cytes of severe TBI patients.
The increase in plasma TBARS and carbonyl levels may
also be related to oxidative stress damage occurring in otherorgans such as lung, liver, muscles, and gastrointestinal tract
of patients with severe TBI associated with multiple trauma,
infections, and hypoxia. Confounding bias may influence the
interpretation of association studies between oxidative stress
markers and the prognosis of TBI. Several clinical,
laboratory, neurosurgical, and radiological variables are
independently associated with the hospital mortality of
severe TBI patients [3]. We believe that the imbalance in the
distribution of admission GCS or pupillary abnormalities in
the small sample of patients of Nayak et al [15,16] (6 deaths,
24 with severe sequelae and 24 with good recovery) could
explain their findings. The use of multiple logistic regression
analysis in a large sample of patients may help determine the
independent association of erythrocyte TBARS levels and
prognosis in human TBI. Differences in the sensitivity of the
applied techniques for TBARS measurements (plasma and
erythrocytes) also need to be considered, and studies
determining the sensibility and specificity of both techniques
may help to clarify this point. The TBARS technique to
measure MDA has received criticism over the years [26].
The technique that mainly measures MDA is not specific
for free radical–induced lipid peroxidation. The MDA may
also be produced during enzymatic lipid peroxidation like
during the arachidonic acid cascade as a product of
prostaglandin synthesis. Thus, the TBARS data are partly a
measure of free radical–induced peroxidation as well as
elevation in prostaglandin synthesis, which is also involved
in the pathophysiology of TBI. Furthermore, MDA and other
lipid peroxidation-derived aldehyde breakdown products
(eg, 4HNE and acrolein) are heavily protein bound; and once
they are bound, they will not react with thiobarbituric acid.
Thus, the TBARS assay only picks up the unbound MDA,
which is the minor portion of the total amount.
Besides, 10 patients died and therefore did not have their
blood drawn. This potential bias cannot be adequately
controlled. If there were an association between the
biomarkers and mortality, this differential loss could have
contributed to the lack of significant findings. The wide
range of TBARS and carbonyl levels in the patient group
523.e18 A. Hohl et al.may lead to a reduced power of the study and may also be a
limitation for the use of these biomarkers.
Our findings indicate that, although patients with TBI
had a progressive increase in the level of plasma markers
for oxidative stress damage at the first 3 days after the
injury, this is probably not a determinant of mortality.
Some recent studies have demonstrated that excitatory
amino acids, which are involved in the core mechanisms of
neuronal injury due to excitotoxicity, also trigger neuro-
protective signals against oxidative stress [27]. If neuro-
protective pathways are activated proportionally to the
level of injury, which in turn is associated with plasma
TBARS and carbonyl levels, then the mortality of patients
with higher levels of those biomarkers may be the same as
that of patients with lower levels. We replicated ours [3]
and other previous studies [28] showing that higher levels
of serum glucose 12 hours after the TBI, lower GCS, and
abnormal pupils at admission [3,28,29] remain indepen-
dently associated with death. In the present study, there
was no association between CT, SAH, and death as
previously demonstrated in our population. This is
probably due to the small sample size of the present
study. The same hypothesis may explain the trend for
higher mortality in patients admitted with anisocoric pupils
as compared with those having isocoric ones. The Injury
Severity Score (or any other score such as the Trauma and
Injury Severity Score or the Revised Trauma Score) has
been demonstrated in other studies to be correlated with
mortality and may be a better outcome predictor than
associated trauma alone. This variable will be included in
further studies.
In conclusion, the increase in plasma TBARS and
protein carbonyl levels seen in the first 70 hours after
severe TBI is not independently associated with hospital
mortality. The association between serum levels of the
oxidative stress markers and both early and long-term
prognosis including fine motor abilities, cognitive, psychi-
atric, and quality of life aspects [4] remains to be
investigated in patients with TBI.
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